Contents

Current Pharmacogenomics, Volume 2 - Number 1

Pharmacogenetics of the Human MDR1 Multidrug Transporter

, 2(1): 1 - 11

Caroline G. Lee, Samuel S. Chong and Edmund J. D.Lee


DOI: 10.2174/1570160043476097




Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease

, 2(1): 13 - 20

Sankar Surendran, Stephen K. Tyring, Kimberlee Michals-Matalon and Reuben Matalon


DOI: 10.2174/1570160043476141




High-throughput Genotyping Methods for Pharmacogenomic Studies

, 2(1): 21 - 33

R. R. Freimuth, M.- M. Ameyaw, S. C. Pritchard, P. Y. Kwok and H. L. McLeod


DOI: 10.2174/1570160043476132




Carotenoids and Modulation of Cancer: Molecular Targets

, 2(1): 35 - 45

Paola Palozza


DOI: 10.2174/1570160043476169




Biology of Protooncogene c-kit Receptor and Spermatogenesis

, 2(1): 47 - 60

Supriya Gangadharan Prasanth, Harleen Mangat Giran and Sher Ali


DOI: 10.2174/1570160043476114




Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy

, 2(1): 61 - 74

M. C. Lansang and N. K. Hollenberg


DOI: 10.2174/1570160043476088




Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)

, 2(1): 75 - 82

R. M. Phillips and S. Basu


DOI: 10.2174/1570160043476079




Candidate Genes in the Pharmacogenomics of Antihypertensive Treatment - A Review and Future Aspects

, 2(1): 83 - 112

P. Hallberg and H. Melhus


DOI: 10.2174/1570160043476123




Author Index to Volume 1

, 2(1): 113

Bentham Science Publishers


DOI: 10.2174/1570160043476150




Subject Index to Volume 1

, 2(1): 115 - 117

Bentham Science Publishers


DOI: 10.2174/1570160043476105




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science